ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,168Medicare Part D Prescriptions Filled, Including Refills

Rank: 28 out of 403

$575K Total Retail Price of All Prescriptions

Rank: 30 out of 403

320 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
49% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 320 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

9% of this provider’s 320 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 6,674 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$70 was the average price of a prescription from this provider, compared to $72 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
LISINOPRIL 400 368 1 1
HYDROCHLOROTHIAZIDE 303 282 2 6
WARFARIN SODIUM 230 230 3 12
SIMVASTATIN 227 217 4 2
FUROSEMIDE 218 217 5 7
ATORVASTATIN CALCIUM 215 176 6 5
ATENOLOL 205 199 7 13
LEVOTHYROXINE SODIUM 199 167 8 3
PRAVASTATIN SODIUM 178 149 9 14
METFORMIN HCL 169 136 10 8
METOPROLOL SUCCINATE 144 131 11 11
LOSARTAN POTASSIUM 141 117 12 21
OMEPRAZOLE 133 95 13 9
FELODIPINE ER 130 130 14 140
LOVASTATIN 108 83 15 42
DIOVAN 101 98 16 24
ZOLPIDEM TARTRATE 100 50 17 16
DONEPEZIL HCL 98 98 18 23
CITALOPRAM HBR 94 79 19 22
HYDROCODONE-ACETAMINOPHEN 90 73 S3 20 15
ALLOPURINOL 86 81 21 31
SERTRALINE HCL 85 51 22 20
AMLODIPINE BESYLATE 82 82 23 4
GLIPIZIDE 74 72 24 70
ALENDRONATE SODIUM 74 56 24 26
METOPROLOL TARTRATE 73 69 26 10
NAMENDA 72 72 27 41
PREDNISONE 71 58 28 34
ADVAIR DISKUS 69 69 29 33
DILTIAZEM 24HR CD 68 61 30 102
SPIRIVA 68 68 30 35
NEXIUM 64 48 32 18
LIPITOR 63 55 33 53
TAMSULOSIN HCL 59 58 34 27
OXYCODONE HCL 58 11 S2 35 39
PRADAXA 57 57 36 199
TRAZODONE HCL 54 41 37 25
ZETIA 53 42 38 59
VENLAFAXINE HCL ER 53 21 38 95
ACTOS 50 35 40 95
NIFEDIPINE ER 50 50 40 122
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 13, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.